Andrew Southan becomes COO at Metrion Biosciences

Metrion Biosciences Ltd
Appointee name
Andrew Southan

United Kingdom

Andrew Southan has been promoted to the position of chief operating officer at Metrion Biosciences Ltd, a contract research organisation (CRO) focused on drug discovery. Mr Southan joined Metrion in October 2016 and has over 25 years of experience in the life sciences industry, 14 years of which involved managing CRO services.

Metrion also appointed James Beaumont as head of business development. Mr Beaumont was previously the business development director at New Zealand Pharmaceuticals Ltd and before that, director of sales at Aptuit LLC.

Metrion Biosciences announced the appointments on 2 May 2017

Copyright 2017 Evernow Publishing Ltd